BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 4077031)

  • 21. Oculocutaneous manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.
    Wilkins J; Morrison L; White CR
    Dermatol Clin; 1992 Jul; 10(3):571-82. PubMed ID: 1617814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lyell's disease, the Stevens-Johnson Syndrome, and exfoliative dermatitis.
    Ostler HB; Conant MA; Groundwater J
    Trans Am Acad Ophthalmol Otolaryngol; 1970; 74(6):1254-65. PubMed ID: 4250164
    [No Abstract]   [Full Text] [Related]  

  • 23. Successful treatment of toxic epidermal necrolysis/Stevens-Johnson syndrome overlap with human granulocyte colony stimulating factor: a case report.
    Pallesen KA; Robinson S; Toft P; Andersen KE
    Acta Derm Venereol; 2012 Mar; 92(2):212-3. PubMed ID: 22068367
    [No Abstract]   [Full Text] [Related]  

  • 24. Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review.
    Gerull R; Nelle M; Schaible T
    Crit Care Med; 2011 Jun; 39(6):1521-32. PubMed ID: 21358399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Erythema multiforme exudativum, Stevens-Johnson syndrome, toxic epidermal necrolysis (Lyell's syndrome) and their interrelationship].
    Kalamkarian AA; Samsonov VA
    Vestn Dermatol Venerol; 1980 Mar; (3):36-42. PubMed ID: 6990649
    [No Abstract]   [Full Text] [Related]  

  • 26. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica.
    East-Innis AD; Thompson DS
    West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of corneal complications with eyelid cicatricial pathologies in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis syndrome.
    Di Pascuale MA; Espana EM; Liu DT; Kawakita T; Li W; Gao YY; Baradaran-Rafii A; Elizondo A; Raju VK; Tseng SC
    Ophthalmology; 2005 May; 112(5):904-12. PubMed ID: 15878074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe gynecologic sequelae of Stevens-Johnson syndrome and toxic epidermal necrolysis caused by ibuprofen: a case report.
    Pliskow S
    J Reprod Med; 2013; 58(7-8):354-6. PubMed ID: 23947089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stevens-Johnson syndrome and toxic epidermal necrolysis overlap in a patient receiving cetuximab and radiotherapy for head and neck cancer.
    Urosevic-Maiwald M; Harr T; French LE; Dummer R
    Int J Dermatol; 2012 Jul; 51(7):864-7. PubMed ID: 22715836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Lyell syndrome or toxic epidermal necrolysis and Stevens-Johnson syndrome after treatment with fluoxetine].
    Bodokh I; Lacour JP; Rosenthal E; Chichmanian RM; Perrin C; Vitetta A; Ortonne JP
    Therapie; 1992; 47(5):441. PubMed ID: 1299992
    [No Abstract]   [Full Text] [Related]  

  • 31. Ethambutol-induced toxic epidermal necrolysis.
    Pegram PS; Mountz JD; O'Bar PR
    Arch Intern Med; 1981 Nov; 141(12):1677-8. PubMed ID: 7305578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Apropos of A. A. Kalamkarian and V. A. Samsonov's article, "Erythema multiforme exudativum, the Stevens-Johnson Syndrome, toxic epidermal necrolysis (Lyell's Syndrome) and their interrelationship"].
    BrailovskiÄ­ AIa
    Vestn Dermatol Venerol; 1980 Nov; (11):29-31. PubMed ID: 7445718
    [No Abstract]   [Full Text] [Related]  

  • 33. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Prendiville J
    Adv Dermatol; 2002; 18():151-73. PubMed ID: 12528405
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome.
    Ghislain PD; Roujeau JC
    Dermatol Online J; 2002 Jun; 8(1):5. PubMed ID: 12165215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Gueudry J; Roujeau JC; Binaghi M; Soubrane G; Muraine M
    Arch Dermatol; 2009 Feb; 145(2):157-62. PubMed ID: 19221260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. European Dermatology Forum: skin diseases in Europe. Skin diseases with a high public health impact: toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Fritsch P
    Eur J Dermatol; 2008; 18(2):216-7. PubMed ID: 18424404
    [No Abstract]   [Full Text] [Related]  

  • 37. Toxic epidermal necrolysis and Stevens-Johnson syndrome: things we should know!
    Kamolz LP; Spendel S; Prandl EC
    Crit Care Med; 2011 Jun; 39(6):1600-1. PubMed ID: 21610649
    [No Abstract]   [Full Text] [Related]  

  • 38. Stevens-Johnson syndrome and toxic epidermal necrolysis-challenges of recognition and management.
    Sane SP; Bhatt AD
    J Assoc Physicians India; 2000 Oct; 48(10):999-1003. PubMed ID: 11200928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Ziemer M; Wiesend CL; Vetter R; Weiss J; Blaschke S; Norgauer J; Mockenhaupt M
    Arch Dermatol; 2007 Jun; 143(6):711-6. PubMed ID: 17576936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxic epidermal necrolysis caused by flurazepam?
    Loncar C; Franić T; Bilusić M
    Psychiatr Danub; 2005 Dec; 17(3-4):236-9. PubMed ID: 16392434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.